Moderna, Inc.: Protecting Against Corporate Espionage
Moderna, Inc.: Protecting Against Corporate Espionage Gray, J.; Turner, K.; Mather, K.; O’Rourke, J. S. (editor) We live in a world where large corporations operate in a matrix of highly competitive markets. Companies in the private biotechnology and pharmaceutical industry have resorted to corporate espionage to gain a competitive advantage. Moderna, Inc., the creator of a highly successful COVID-19 vaccine, has accused competitors, including BioNTech and Pfizer of data attacks conducted as a form of corporate espionage. Executives at Moderna are now faced with maintaining a balance between protecting public health and safeguarding its own research.